What laxatives after hip surgery?

Phase 1

• Conditions: Hip fracture; Therapeutic area: Phenomena and Processes [G] - Musculoskeletal and Neural Physiological Phenomena [G11]

• Registration Number: CTIS2024-513871-42-00
• Lead Sponsor: Odense University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-13
• Last Update Posted: 21 August 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 375

Inclusion Criteria

• Acute hip fracture surgery patients from one of two orthopedic departments from hospitals in the Southern Region of Denmark. • Age= 65 years • The patients should be able to speak and understand Danish

Exclusion Criteria

with known chronic constipation (defined from Wexner constipation score) • with known use of laxatives at admission • who participate in other similar clinical studies • who is terminally ill • who is restraint • who is in isolation • with severe heart disease defined as New York Heart Association (NYHA) III og IV • with severe chronically inflammatory bowel disease • with acute abdominal surgical conditions, eg. ileus, obstruction or perforation • with dysphagia where the patient can not swallow tablets/oral liquids • with toxic megacolon • with gastric emptying disorder • with severe electrolyte disorder (P-kalium: < 2.5 mmol/l og P-natrium: <125 mmol/l) • Allergies to the ingredients • Pregnant women can not be included but the women are expected to be postmenopausal why pregnancy test are not performed

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified